🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is studying the safety and efficacy of a personalized c...
Status
Recruiting
Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Start Date
2024-03-01
Trial ID
NCT07002203
Treatments Being Tested
The Investigators have demonstrated in preclinical studies that RNA liposom...
Status
Active Not Recruiting
Location
UF Health
Start Date
2025-03-12
Trial ID
NCT05660408
Treatments Being Tested
The main purpose of this study is to determine whether adding SurVaxM to st...
Status
Unknown
Location
University of California
Start Date
2021-11-18
Trial ID
NCT05163080
Treatments Being Tested
The goal of this clinical research study is to learn if the drug leuprolide...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-11
Trial ID
NCT00254397
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-06
Trial ID
NCT00003819
Treatments Being Tested
This is a multicentre observational study with the aim of evaluating the an...
Status
Completed
Location
IRCCS Istituto Tumori Giovanni Paolo II
Start Date
2021-04-19
Trial ID
NCT04848493
Treatments Being Tested
This is a phase I/II study to determine the safety and gain insight into th...
Status
Completed
Location
Duke University Medical Center
Start Date
2009-07
Trial ID
NCT00952692
Treatments Being Tested
This clinical trial aims to evaluate the safety, immunogenicity, and prelim...
Status
Completed
Location
Vejthani Hospital
Start Date
2022-11-24
Trial ID
NCT06614140
Treatments Being Tested
This is a phase 1b study of P30-linked EphA2, CMV pp65, and survivin vaccin...
Status
Active Not Recruiting
Location
The Preston Robert Tisch Brain Tumor Center at Duke University
Start Date
2023-08-30
Trial ID
NCT05283109
Treatments Being Tested
A randomised, open-label, 2-arm, multi-centre, phase II clinical study with...
Status
Completed
Location
Landesnervenklinik Wagner-Jauregg
Start Date
2010-04
Trial ID
NCT01213407
Treatments Being Tested